Scott H Britz-Cunningham1, John W Millstine, Victor H Gerbaudo. 1. Division of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. sbritzcunningham@partners.org
Abstract
PURPOSE: This study demonstrates a simple background correction method, which improves the discrimination of benign from malignant lesions on FDG PET-CT imaging, using activity ratios compared with brain, basal ganglia, or cerebellum. METHODS: Standardized uptake values (SUVs) and comparative activity ratios (CARs) were determined for FDG uptake in 92 lesions (39 benign and 53 malignant) in 49 patients. Reference tissues included cerebral cortex, basal ganglia, cerebellum, lung, liver, and aortic blood pool. Discriminant power for each CAR was evaluated as malignant-to-benign ratio of mean uptake and ratio of intermediate-likelihood lesions to total number of lesions. RESULTS: Uncorrected SUV varied widely for malignant and benign lesions, with considerable overlap. Ratio of mean uptake for malignant lesions versus benign lesions was lowest for uncorrected SUVAVG and SUVAVG/liver (1.92), and highest for SUVMAX/cerebral cortex (3.52). Lesions could be separated into very high (> 90%), very low (< 10%), and intermediate (> or = 10% and < or = 90%) likelihood of malignancy. The ratio of intermediate-likelihood lesions to the total number of lesions was greatest for SUVAVG (0.42) and lowest for SUVMAX/basal ganglia (0.22). CONCLUSIONS: Ability to discriminate malignant from benign lesions was enhanced by using CARs derived from cerebral cortex, basal ganglia, or cerebellum. Using a 3-tiered diagnostic schema, most lesions could be assigned to categories of very high or very low likelihood of malignancy, with a significant reduction in indeterminant lesions, compared with uncorrected SUV.
PURPOSE: This study demonstrates a simple background correction method, which improves the discrimination of benign from malignant lesions on FDG PET-CT imaging, using activity ratios compared with brain, basal ganglia, or cerebellum. METHODS: Standardized uptake values (SUVs) and comparative activity ratios (CARs) were determined for FDG uptake in 92 lesions (39 benign and 53 malignant) in 49 patients. Reference tissues included cerebral cortex, basal ganglia, cerebellum, lung, liver, and aortic blood pool. Discriminant power for each CAR was evaluated as malignant-to-benign ratio of mean uptake and ratio of intermediate-likelihood lesions to total number of lesions. RESULTS: Uncorrected SUV varied widely for malignant and benign lesions, with considerable overlap. Ratio of mean uptake for malignant lesions versus benign lesions was lowest for uncorrected SUVAVG and SUVAVG/liver (1.92), and highest for SUVMAX/cerebral cortex (3.52). Lesions could be separated into very high (> 90%), very low (< 10%), and intermediate (> or = 10% and < or = 90%) likelihood of malignancy. The ratio of intermediate-likelihood lesions to the total number of lesions was greatest for SUVAVG (0.42) and lowest for SUVMAX/basal ganglia (0.22). CONCLUSIONS: Ability to discriminate malignant from benign lesions was enhanced by using CARs derived from cerebral cortex, basal ganglia, or cerebellum. Using a 3-tiered diagnostic schema, most lesions could be assigned to categories of very high or very low likelihood of malignancy, with a significant reduction in indeterminant lesions, compared with uncorrected SUV.
Authors: Thomas Christen; Yuri Sheikine; Viviane Z Rocha; Shelley Hurwitz; Allison B Goldfine; Marcelo Di Carli; Peter Libby Journal: JACC Cardiovasc Imaging Date: 2010-08
Authors: Michael T Osborne; Amorina Ishai; Basma Hammad; Brian Tung; Ying Wang; Amos Baruch; Zahi A Fayad; Jon T Giles; Janet Lo; Lisa M Shin; Steven K Grinspoon; Karestan C Koenen; Roger K Pitman; Ahmed Tawakol Journal: Psychoneuroendocrinology Date: 2018-09-22 Impact factor: 4.905
Authors: Virendra Kumar; Kavindra Nath; Claudia G Berman; Jongphil Kim; Tawee Tanvetyanon; Alberto A Chiappori; Robert A Gatenby; Robert J Gillies; Edward A Eikman Journal: Clin Nucl Med Date: 2013-03 Impact factor: 7.794
Authors: Tawseef Dar; Michael T Osborne; Shady Abohashem; Taimur Abbasi; Karmel W Choi; Ahmed Ghoneem; Nicki Naddaf; Jordan W Smoller; Roger K Pitman; John W Denninger; Lisa M Shin; Gregory Fricchione; Ahmed Tawakol Journal: Circ Cardiovasc Imaging Date: 2020-08-13 Impact factor: 7.792
Authors: Azar Radfar; Shady Abohashem; Michael T Osborne; Ying Wang; Tawseef Dar; Malek Z O Hassan; Ahmed Ghoneem; Nicki Naddaf; Tomas Patrich; Taimur Abbasi; Hadil Zureigat; James Jaffer; Parastou Ghazi; James A Scott; Lisa M Shin; Roger K Pitman; Tomas G Neilan; Malissa J Wood; Ahmed Tawakol Journal: Eur Heart J Date: 2021-05-14 Impact factor: 35.855
Authors: I R Macdonald; D R DeBay; G A Reid; T P O'Leary; C T Jollymore; G Mawko; S Burrell; E Martin; C V Bowen; R E Brown; S Darvesh Journal: Curr Alzheimer Res Date: 2014 Impact factor: 3.498